KARYOPHARM THERAPEUTICS INC (KPTI)
US48576U1060 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to KPTI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.68. This target is 402.91% above the current price.
KPTI was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KPTI.
In the previous month the buy percentage consensus was at a similar level.
KPTI was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-26 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-05 | RBC Capital | Maintains | Outperform |
| 2023-05-05 | Baird | Maintains | Outperform |
| 2023-05-05 | HC Wainwright & Co. | Maintains | Buy |
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-22 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-27 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-19 | Piper Sandler | Initiate | Overweight |
| 2023-01-10 | SVB Leerink | Maintains | Market Perform |
| 2023-01-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-04 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2022-11-04 | SVB Leerink | Maintains | Market Perform |
| 2022-09-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-05 | Barclays | Maintains | Overweight |
| 2022-08-05 | Baird | Maintains | Outperform |
| 2022-08-05 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-05 | SVB Leerink | Maintains | Market Perform |
| 2022-03-08 | RBC Capital | Maintains | Sector Perform |
| 2022-03-02 | SVB Leerink | Maintains | Market Perform |
| 2022-02-09 | JP Morgan | Upgrade | Underweight -> Neutral |